Purpose This study aimed to evaluate the virucidal efficacy of 0.4% povidone-iodine (PVP-I)
nasal spray against SARS-CoV-2 in the patients' nasopharynx at 3 minutes and 4 hours after …

Background: Nasal disinfection with 0.5% povidone-iodine (PVP-I) may be a useful adjunct
in the management of COVID-19. The purpose of this article is to confirm the in vitro activity …

Objective A Phase II trial was conducted to determine if nasal disinfection with a commercial
Good Manufacturing Practice‐manufactured 0.5% povidone‐iodine nasal spray …

Objectives/Hypothesis To determine the effect of povidone‐iodine (PVP‐I) nasal sprays on
nasopharyngeal (NP) viral load as assessed by cycle threshold (Ct) on quantitative …

Abstract Povidone-iodine (PVP-I) is a time-tested antiseptic agent with excellent virucidal
(99.99%) properties. Repurposing it against coronavirus disease-19 (COVID-19) is a …

Abstract Objective General: To assess the virucidal efficacy of povidone iodine (PVP-I) on
COVID-19 virus located in the nasopharynx Specific: i. To evaluate the efficacy of povidone …

Importance Research is needed to demonstrate the efficacy of nasal povidone-iodine (PVP-
I) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Objective To …

Abstract Objectives/Hypothesis To assess the efficacy of 0.23% povidone-iodine (PVP-I)
nasal rinses and mouth washes on detectability of the coronavirus disease 2019 (COVID …

Introduction: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the
pathogen responsible for the global pandemic of coronavirus disease 2019 (COVID-19) …

Methods| We included adult outpatients (≥ 18 years old) having tested highly positive (cycle
threshold≤ 20) for SARS-CoV-2 ribonucleic acid (RNA) by reverse transcriptionpolymerase …